Recombinant multi-species FCRL3/CD307c protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FCRL3/CD307c protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the immunoglobulin receptor superfamily and is one of several Fc receptor-like glycoproteins clustered on the long arm of chromosome 1. The encoded protein contains immunoreceptor-tyrosine activation motifs and immunoreceptor-tyrosine inhibitory motifs in its cytoplasmic domain and may play a role in regulation of the immune system. Mutations in this gene have been associated with rheumatoid arthritis, autoimmune thyroid disease, and systemic lupus erythematosus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
The Alternative Names of target: CD307c,FCRH3,FCRL3,Fc receptor homolog 3 (FcRH3),Fc receptor-like protein 3,FcR-like protein 3,FcRL3,IFGP family protein 3 (hIFGP3),IFGP3,IRTA3,Immune receptor translocation-associated protein 3,MAIA,SH2 domain-containing phosphatase anchor protein 2,SPAP2

Target products collectionGo to FCRL3/CD307c products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0841-Ag-1/ GM-Tg-hg-IP0841-Ag-2 Human FCRL3/CD307c protein Human
GM-Tg-rg-IP0841-Ag-1/ GM-Tg-rg-IP0841-Ag-2 Rat FCRL3/CD307c protein Rat
GM-Tg-mg-IP0841-Ag-1/ GM-Tg-mg-IP0841-Ag-2 Mouse FCRL3/CD307c protein Mouse
GM-Tg-cynog-IP0841-Ag-1/ GM-Tg-cynog-IP0841-Ag-2 Cynomolgus/Rhesus macaque FCRL3/CD307c protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0841-Ag-1/ GM-Tg-felg-IP0841-Ag-2 Feline FCRL3/CD307c protein Feline
GM-Tg-cang-IP0841-Ag-1/ GM-Tg-cang-IP0841-Ag-2 Canine FCRL3/CD307c protein Canine
GM-Tg-bovg-IP0841-Ag-1/ GM-Tg-bovg-IP0841-Ag-2 Bovine FCRL3/CD307c protein Bovine
GM-Tg-equg-IP0841-Ag-1/ GM-Tg-equg-IP0841-Ag-2 Equine FCRL3/CD307c protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0841-Ag-1/ GM-Tg-hg-IP0841-Ag-2; GM-Tg-rg-IP0841-Ag-1/ GM-Tg-rg-IP0841-Ag-2;
GM-Tg-mg-IP0841-Ag-1/ GM-Tg-mg-IP0841-Ag-2; GM-Tg-cynog-IP0841-Ag-1/ GM-Tg-cynog-IP0841-Ag-2;
GM-Tg-felg-IP0841-Ag-1/ GM-Tg-felg-IP0841-Ag-2; GM-Tg-cang-IP0841-Ag-1/ GM-Tg-cang-IP0841-Ag-2;
GM-Tg-bovg-IP0841-Ag-1/ GM-Tg-bovg-IP0841-Ag-2; GM-Tg-equg-IP0841-Ag-1/ GM-Tg-equg-IP0841-Ag-2
Products Name FCRL3/CD307c protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name FCRL3/CD307c
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FCRL3/CD307c protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.